David N. Palmer

4.1k citations

87 papers · 3.3k indexed · 1 hit paper · h-index 32

Physiology top 0.5%
Molecular Biology top 5%
Cell Biology top 1%
Neurology top 2%
Epidemiology top 10%

Co-authors: R.D. Jolly Ryan D. Martinus Ian M. Fearnley Jaana Tyynelä John E. Walker Graham W. Kay Matti Haltia Nadia L. Mitchell
Topics: Lysosomal Storage Disorders Research (61 papers)Glycogen Storage Diseases and Myoclonus (11 papers)Mitochondrial Function and Pathology (10 papers)
Cited by: Physiology Cell Biology
Journals: Journal of Biological ChemistrySHILAP Revista de lepidopterologíaThe Journal of Immunology
Partner nations: New Zealand United Kingdom United States

In The Last Decade

David N. Palmer

86 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mitochondrial ATP synthase subunit c storage in the ceroid‐lipofuscinoses (Batten disease)

1992 314 citations David N. Palmer, Ian M. Fearnley et al. American Journal of Medical Genetics profile →

Peers

Countries citing papers authored by David N. Palmer

Since Specialization

Citations

This map shows the geographic impact of David N. Palmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David N. Palmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David N. Palmer more than expected).

Fields of papers citing papers by David N. Palmer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David N. Palmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David N. Palmer. The network helps show where David N. Palmer may publish in the future.

Co-authorship network of co-authors of David N. Palmer

This figure shows the co-authorship network connecting the top 25 collaborators of David N. Palmer. A scholar is included among the top collaborators of David N. Palmer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David N. Palmer. David N. Palmer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Design and Fabrication Issues for Small-Scale SMES 2024 ·OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) ·J.R. Hull,Susan Schoenung,David N. Palmer,(unknown)	0
2	Efficacy of dual intracerebroventricular and intravitreal CLN5 gene therapy in sheep prompts the first clinical trial to treat CLN5 Batten disease 2023 ·Frontiers in Pharmacology ·(unknown),Martin Wellby,Graham K. Barrell,(unknown),(unknown),(unknown),Steven J. Gray,David N. Palmer,Nadia L. Mitchell	4
3	Modelling Neurological Diseases in Large Animals: Criteria for Model Selection and Clinical Assessment 2022 ·Cells ·Samantha L. Eaton,(unknown),Nina M. Rzechorzek,Gerard Thompson,Claudia Hartley,B. Blacklock,Chris Proudfoot,Simon Lillico,Peter W. G. Tennant,(unknown),(unknown),Paul M. Brennan,(unknown),Nadia L. Mitchell,David N. Palmer,Bruce Whitelaw,Jonathan D. Cooper,Thomas M. Wishart	4
4	Intravitreal gene therapy protects against retinal dysfunction and degeneration in sheep with CLN5 Batten disease 2021 ·Experimental Eye Research ·(unknown),(unknown),Tracy R. Melzer,Steven J. Gray,(unknown),David N. Palmer,Nadia L. Mitchell	19
5	Urine proteomics analysis of patients with neuronal ceroid lipofuscinoses 2020 ·iScience ·Katharina Iwan,Robert Clayton,Philippa B. Mills,(unknown),Paul Gissen,Sara Mole,David N. Palmer,Kevin Mills,Wendy Heywood	12
6	The relevance of the storage of subunit c of ATP synthase in different forms and models of Batten disease (NCLs) 2015 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·David N. Palmer	27
7	Recent studies of ovine neuronal ceroid lipofuscinoses from BARN, the Batten Animal Research Network 2015 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·David N. Palmer,(unknown),(unknown),(unknown),Peter J. Houweling,(unknown),Imke Tammen,Stephanie M. Hughes,Nadia L. Mitchell	26
8	Conservation of Complete Trimethylation of Lysine-43 in the Rotor Ring of c-Subunits of Metazoan Adenosine Triphosphate (ATP) Synthases* 2015 ·Molecular & Cellular Proteomics ·(unknown),David N. Palmer,(unknown),Shujing Ding,Ian M. Fearnley,John E. Walker	23
9	Inhibition of storage pathology in prenatal CLN5-deficient sheep neural cultures by lentiviral gene therapy 2013 ·Neurobiology of Disease ·Stephanie M. Hughes,(unknown),(unknown),Nadia L. Mitchell,David N. Palmer	31
10	Neuronal ceroid lipofuscinosis in Devon cattle is caused by a single base duplication (c.662dupG) in the bovine CLN5 gene 2006 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Peter J. Houweling,Julie Cavanagh,David N. Palmer,Tony Frugier,Nadia L. Mitchell,Peter Windsor,Herman W. Raadsma,Imke Tammen	32
11	The development and characterisation of complex ovine neuron cultures from fresh and frozen foetal neurons 2006 ·Journal of Neuroscience Methods ·Graham W. Kay,M.J. Oswald,David N. Palmer	11
12	Changes in GABAergic neuron distribution in situ and in neuron cultures in ovine (OCL6) Batten disease 2001 ·European Journal of Paediatric Neurology ·M.J. Oswald,Graham W. Kay,David N. Palmer	31
13	Different Patterns of Hydrophobic Protein Storage in Different Forms of Neuronal Ceroid Lipofuscinosis (NCL, Batten Disease) 1997 ·Neuropediatrics ·David N. Palmer,R.D. Jolly,(unknown),Jaana Tyynelä,(unknown)	59
14	Use of Electrospray Ionization Mass Spectrometry and Tandem Mass Spectrometry to Study Binding of F0 Inhibitors to Ceroid Lipofuscinosis Protein, a Model System for Subunit c of Mitochondrial ATP Synthase 1996 ·Rapid Communications in Mass Spectrometry ·Armelle Buzy,(unknown),Keith R. Jennings,David N. Palmer,David E. Griffiths	19
15	The Neuronal Ceroid Lipofuscinoses (Batten Disease) 1996 ·Advances in experimental medicine and biology ·David N. Palmer,John Hay	21
16	The neuronal ceroid‐Iipofuscinoses (Batten disease): comparative aspects 1995 ·Neuropathology and Applied Neurobiology ·R.D. Jolly,David N. Palmer	37
17	Storage of saposins A and D in infantile neuronal ceroid‐lipofuscinosis 1993 ·FEBS Letters ·Jaana Tyynelä,David N. Palmer,Marc Baumann,Matti Haltia	146
18	Mitochondrial ATP synthase subunit c storage in the ceroid‐lipofuscinoses (Batten disease)breakdown → 1992 ·American Journal of Medical Genetics ·David N. Palmer,Ian M. Fearnley,John E. Walker,Nicholas A. Hall,Brian Lake,Leonhard S. Wolfe,Matti Haltia,Ryan D. Martinus,R.D. Jolly	314
19	Ovine ceroid-lipofuscinosis II: Pathologic changes interpreted in light of biochemical observations 1988 ·American Journal of Medical Genetics ·R.D. Jolly,Armando S. Shimada,A. S. Craig,Kathryn B. Kirkland,David N. Palmer,John M. Opitz,James F. Reynolds,Raju K. Pullarkat	32
20	Ovine ceroid-lipofuscinosis I: Lipopigment composition is indicative of a lysosomal proteinosis 1988 ·American Journal of Medical Genetics ·David N. Palmer,Ryan D. Martinus,(unknown),Roger D. Reeves,R.D. Jolly,John M. Opitz,James F. Reynolds,Raju K. Pullarkat	56

About David N. Palmer

David N. Palmer is a scholar working on Physiology, Neurology and Clinical Biochemistry, having authored 87 papers that have together received 3.3k indexed citations. Recurring topics across this work include Lysosomal Storage Disorders Research (61 papers), Glycogen Storage Diseases and Myoclonus (11 papers) and Mitochondrial Function and Pathology (10 papers). The work is most often cited by research in Physiology (2.1k citations), Physiology (326 citations) and Cell Biology (924 citations). David N. Palmer has collaborated with scholars based in New Zealand, United Kingdom and United States. Frequent co-authors include R.D. Jolly, Ryan D. Martinus, Ian M. Fearnley, Jaana Tyynelä, John E. Walker, Graham W. Kay, Matti Haltia, Nadia L. Mitchell, Jonathan D. Cooper and Nicholas A. Hall. Their work appears in journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact